BioEcho Life Sciences, the biotechnology company that provides rapid and sustainable technologies for nucleic acid extraction, has launched its latest product: the EchoLution Tissue RNA Kit — designed for optimized total RNA extraction from mammalian tissue, including difficult tissues such as muscles.

“We are delighted to present the EchoLution Tissue RNA Kit,” said Christiane Schlottbom, Director Marketing at BioEcho Life Sciences. “This innovative solution represents a significant advance in RNA extraction technology and provides researchers with unparalleled speed, efficiency, and reliability in their experiments. We are convinced that the EchoLution Tissue RNA Kit will significantly simplify the workflows of scientists working in various areas of molecular biology, as it provides high-quality RNA without the need for phenol/chloroform.”

The EchoLution Tissue RNA Kit offers numerous advantages over traditional methods and offers researchers flexibility and versatility. The kit is suitable for a wide range of freshly frozen or stabilized tissues. The product significantly reduces the time required and increases efficiency in the laboratory. One-step purification combined with ultra-fast tissue lysis enables the complete extraction of 96 samples within 35 minutes. The result is a high-purity RNA that is free of contaminants and inhibitors and ensures reliable and reproducible results in downstream applications such as RT-qPCR and RNA-seq.

In addition, the EchoLution Tissue RNA Kit reinforces BioEcho's commitment to sustainability and environmentally responsible practices, as up to 50% less plastic is used compared to other extraction methods and no longer requires hazardous reagents.

For more information about the EchoLution Tissue RNA kit and workflow, visit www.bioecho.com/tissue-RNA or email BioEcho at contact@bioecho.de.

‍

About BioEcho Life Sciences GmbH

BioEcho Life Sciences is a specialized solution provider for nucleic acid extraction and analysis. We develop disruptive technologies, products and workflows that make the processing of nucleic acids significantly easier and faster, significantly increase throughput and deliver reliable results. Our patented EchoLution™ technology enables the fastest DNA and RNA extraction on the market today in just one step and reduces the associated plastic waste by up to 70%.

BioEcho was founded in 2016 by leading industry experts. The company is headquartered in Cologne, which is certified according to ISO 9001 and ISO 13485.

‍

BioEcho. The Nucleic Acid Experts.

www.bioecho.com

‍

Contact for press inquiries:

Dr. Laura Torres Benito, Scientific Communications Manager

Office: +49 221 998897-24

E-mail: laura.torres.benito@bioecho.de

‍

BioEcho Life Sciences, the biotechnology company that provides rapid and sustainable technologies for nucleic acid extraction, has launched its latest product: the EchoLution Tissue RNA Kit — designed for optimized total RNA extraction from mammalian tissue, including difficult tissues such as muscles.

“We are delighted to present the EchoLution Tissue RNA Kit,” said Christiane Schlottbom, Director Marketing at BioEcho Life Sciences. “This innovative solution represents a significant advance in RNA extraction technology and provides researchers with unparalleled speed, efficiency, and reliability in their experiments. We are convinced that the EchoLution Tissue RNA Kit will significantly simplify the workflows of scientists working in various areas of molecular biology, as it provides high-quality RNA without the need for phenol/chloroform.”

The EchoLution Tissue RNA Kit offers numerous advantages over traditional methods and offers researchers flexibility and versatility. The kit is suitable for a wide range of freshly frozen or stabilized tissues. The product significantly reduces the time required and increases efficiency in the laboratory. One-step purification combined with ultra-fast tissue lysis enables the complete extraction of 96 samples within 35 minutes. The result is a high-purity RNA that is free of contaminants and inhibitors and ensures reliable and reproducible results in downstream applications such as RT-qPCR and RNA-seq.

In addition, the EchoLution Tissue RNA Kit reinforces BioEcho's commitment to sustainability and environmentally responsible practices, as up to 50% less plastic is used compared to other extraction methods and no longer requires hazardous reagents.

For more information about the EchoLution Tissue RNA kit and workflow, visit www.bioecho.com/tissue-RNA or email BioEcho at contact@bioecho.de.

‍

About BioEcho Life Sciences GmbH

BioEcho Life Sciences is a specialized solution provider for nucleic acid extraction and analysis. We develop disruptive technologies, products and workflows that make the processing of nucleic acids significantly easier and faster, significantly increase throughput and deliver reliable results. Our patented EchoLution™ technology enables the fastest DNA and RNA extraction on the market today in just one step and reduces the associated plastic waste by up to 70%.

BioEcho was founded in 2016 by leading industry experts. The company is headquartered in Cologne, which is certified according to ISO 9001 and ISO 13485.

‍

BioEcho. The Nucleic Acid Experts.

www.bioecho.com

‍

Contact for press inquiries:

Dr. Laura Torres Benito, Scientific Communications Manager

Office: +49 221 998897-24

E-mail: laura.torres.benito@bioecho.de

‍